Adicet Bio, Inc.
ACET
$9.64
-$0.09-0.93%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -21.36M | -20.24M | -30.52M | -26.86M | -31.22M |
| Total Depreciation and Amortization | 1.20M | 1.34M | 1.47M | 1.57M | 1.66M |
| Total Amortization of Deferred Charges | -- | -- | 28.00K | 0.00 | 0.00 |
| Total Other Non-Cash Items | 1.56M | 1.26M | 5.47M | 2.51M | 2.87M |
| Change in Net Operating Assets | -1.23M | -3.84M | 2.64M | 470.00K | 58.00K |
| Cash from Operations | -19.82M | -21.49M | -20.91M | -22.31M | -26.63M |
| Capital Expenditure | -202.00K | -37.00K | 10.00K | -209.00K | -47.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 16.85M | 18.92M | -44.55M | 17.05M | 33.00M |
| Cash from Investing | 16.65M | 18.88M | -44.54M | 16.84M | 32.95M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 0.00 | -150.00K | -- |
| Issuance of Common Stock | 83.00K | -- | 75.23M | 0.00 | 267.00K |
| Repurchase of Common Stock | -3.00K | -65.00K | 0.00 | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -22.00K | -- | -- | -- | -- |
| Cash from Financing | 58.00K | -65.00K | 75.23M | -150.00K | 267.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.11M | -2.68M | 9.79M | -5.62M | 6.59M |